Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.
Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M. Nikolic D, et al. Among authors: montalto g. Curr Pharm Des. 2017 Mar 26;23(6):894-902. doi: 10.2174/1381612822666161006151134. Curr Pharm Des. 2017. PMID: 27719644 Review.
Subfractions and subpopulations of HDL: an update.
Rizzo M, Otvos J, Nikolic D, Montalto G, Toth PP, Banach M. Rizzo M, et al. Among authors: montalto g. Curr Med Chem. 2014;21(25):2881-91. doi: 10.2174/0929867321666140414103455. Curr Med Chem. 2014. PMID: 24735362 Review.
A review of the cardiovascular and anti-atherogenic effects of ghrelin.
Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER. Rizzo M, et al. Among authors: montalto g. Curr Pharm Des. 2013;19(27):4953-63. doi: 10.2174/1381612811319270018. Curr Pharm Des. 2013. PMID: 23278489 Review.
PCSK9 inhibition - a novel mechanism to treat lipid disorders?
Banach M, Rizzo M, Obradovic M, Montalto G, Rysz J, Mikhailidis DP, Isenovic ER. Banach M, et al. Among authors: montalto g. Curr Pharm Des. 2013;19(21):3869-77. doi: 10.2174/13816128113199990303. Curr Pharm Des. 2013. PMID: 23286435 Review.
The role of fibrate treatment in dyslipidemia: an overview.
Katsiki N, Nikolic D, Montalto G, Banach M, Mikhailidis DP, Rizzo M. Katsiki N, et al. Among authors: montalto g. Curr Pharm Des. 2013;19(17):3124-31. doi: 10.2174/1381612811319170020. Curr Pharm Des. 2013. PMID: 23317397 Review.
Statins and new-onset diabetes.
Barylski M, Nikolic D, Banach M, Toth PP, Montalto G, Rizzo M. Barylski M, et al. Among authors: montalto g. Curr Pharm Des. 2014;20(22):3657-64. doi: 10.2174/13816128113196660678. Curr Pharm Des. 2014. PMID: 24040871 Review.
The effect of bergamot on dyslipidemia.
Giglio RV, Patti AM, Nikolic D, Li Volti G, Al-Rasadi K, Katsiki N, Mikhailidis DP, Montalto G, Ivanova E, Orekhov AN, Rizzo M. Giglio RV, et al. Among authors: montalto g. Phytomedicine. 2016 Oct 15;23(11):1175-81. doi: 10.1016/j.phymed.2015.12.005. Epub 2015 Dec 30. Phytomedicine. 2016. PMID: 26851838 Review.
480 results